Concentrix Corporation
CNXC
$39.60
-$0.71-1.76%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.48B | 2.42B | 2.37B | 2.45B | 2.39B |
| Total Other Revenue | -- | -- | -- | -- | 575.94M |
| Total Revenue | 2.48B | 2.42B | 2.37B | 2.45B | 2.39B |
| Cost of Revenue | 1.63B | 1.57B | 1.52B | 1.58B | 1.52B |
| Gross Profit | 855.01M | 848.15M | 855.90M | 870.60M | 864.19M |
| SG&A Expenses | 577.79M | 573.95M | 667.44M | 215.11M | 557.76M |
| Depreciation & Amortization | 111.78M | 109.16M | -- | 458.93M | 116.56M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.32B | 2.25B | 2.18B | 2.25B | 2.20B |
| Operating Income | 165.44M | 165.04M | 188.46M | 196.56M | 189.88M |
| Income Before Tax | 111.44M | 51.72M | 100.79M | 112.91M | 26.42M |
| Income Tax Expenses | 23.33M | 9.63M | 30.54M | -2.74M | 9.79M |
| Earnings from Continuing Operations | 88.11M | 42.09M | 70.26M | 115.65M | 16.63M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 88.11M | 42.09M | 70.26M | 115.65M | 16.63M |
| EBIT | 165.44M | 165.04M | 188.46M | 196.56M | 189.88M |
| EBITDA | 333.99M | 330.35M | 349.17M | 365.28M | 366.00M |
| EPS Basic | 1.34 | 0.63 | 1.04 | 1.73 | 0.25 |
| Normalized Basic EPS | 1.27 | 0.76 | 1.14 | 1.50 | 0.71 |
| EPS Diluted | 1.34 | 0.63 | 1.04 | 1.73 | 0.25 |
| Normalized Diluted EPS | 1.27 | 0.76 | 1.14 | 1.50 | 0.70 |
| Average Basic Shares Outstanding | 62.60M | 63.36M | 64.04M | 64.32M | 64.66M |
| Average Diluted Shares Outstanding | 62.70M | 63.41M | 64.07M | 64.35M | 64.75M |
| Dividend Per Share | 0.33 | 0.33 | 0.33 | 0.33 | 0.30 |
| Payout Ratio | 24.82% | 52.59% | 31.86% | 19.57% | 121.54% |